Compliance with serial dermoscopic monitoring: An academic perspective - 14/11/16
Abstract |
Background |
For even seasoned practitioners, early melanomas can be difficult to distinguish from melanocytic nevi. Although serial digital dermoscopy is considered by many to be the gold standard for monitoring patients at high risk, poor compliance can seriously alter efficacy. In 2014, a concerning compliance rate of 25% was reported from a single, private clinic. Information is currently limited regarding the determinants of compliance and whether patients at high risk return at an acceptable rate.
Objective |
We sought to determine the compliance rate within the pigmented lesions clinic at our academic institution and identify demographic variables that may influence adherence.
Methods |
A retrospective review was conducted using 120 patient charts.
Results |
An overall compliance rate of 87.5% was observed with 63.3% of patients returning within 1 month of the recommended interval. The most notable risk factor for noncompliance was patient age between 20 and 29 years. Factors promoting adherence include a personal history of melanoma, greater than 5 serially monitored nevi, and a personal history of atypical nevi.
Limitations |
The external validity is limited and the sample size is small.
Conclusion |
These findings contradict concerns that adherence to serial monitoring is unacceptably poor and demonstrate that compliance is highest for patients with the greatest inherent risk.
Le texte complet de cet article est disponible en PDF.Key words : compliance, dermoscopy, digital dermoscopy, melanoma, nevi, serial dermoscopy
Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
Vol 75 - N° 6
P. 1171-1175 - décembre 2016 Retour au numéro
Article précédent
- Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis
- Steven R. Feldman, Diamant Thaçi, Melinda Gooderham, Matthias Augustin, Claudia de la Cruz, Lotus Mallbris, Marjorie Buonanno, Svitlana Tatulych, Mandeep Kaur, Shuping Lan, Hernan Valdez, Carla Mamolo
- Imaging mass spectrometry assists in the classification of diagnostically challenging atypical Spitzoid neoplasms
- Rossitza Lazova, Erin H. Seeley, Heinz Kutzner, Richard A. Scolyer, Glynis Scott, Lorenzo Cerroni, Isabella Fried, Milena E. Kozovska, Arlene S. Rosenberg, Victor G. Prieto, Bahig M. Shehata, Megan M. Durham, Gina Henry, Jose L. Rodriguez-Peralto, Erica Riveiro-Falkenbach, Jochen T. Schaefer, Richard Danialan, Sylvie Fraitag, Sonja Vollenweider-Roten, Alireza Sepehr, Martin Sangueza, Nouf Hijazi, Yamile Corredoira, Rachel Kowal, Olga M. Harris, Francisco Bravo, Alan S. Boyd, Ralitza Gueorguieva, Richard M. Caprioli
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?